Clinical trial
Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole…
NCT00230516 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00230516 |
|---|---|
| Title | Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects |
| Official title | A Randomized, Open-Label, Comparative, Two-Treatment, Crossover Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects on Days 1 and 5 of Intravenous Treatment |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Nexium, Prevacid |
| Enrollment | 100 |
| Start date | Sep 1, 2005 |
| Completion | Feb 1, 2006 |
| First posted | Oct 3, 2005 |
| Last update posted | Jan 4, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: